Posted:
2/13/2024, 11:15:20 AM
Location(s):
Redwood City, California, United States
Experience Level(s):
Senior
Field(s):
Business & Strategy
About Earli
Earli exists to make cancer a benign experience. Earli does that by turning cancers against themselves: genetically forcing them to reveal themselves early, and then kill themselves – precisely and clearly distinguishable from benign lesions at early stages. Based on original technology from Stanford’s renowned Gambhir lab, Earli designs genetic constructs that are injected intravenously that turn cancer cells against themselves. These programmable synthetic promoter-reporter sequences “flip on” like light switches only in dysregulated cancer cells and turn them into "factories." The cancer is forced to produce either an epitope “docking station” for imaging agents, or a cytokine for immune system activation against the tumor. Thus, Earli’s platform enables immediate diagnosis and treatment of early cancers, rather than long-term observation that can lead to deadly metastatic recurrence.
Earli's synthetic target expression platform has evolved over five years of deep bioengineering. The system can now detect broad ranges of patient mutations, distinguish between malignant and benign lesions, and offer independence from often elusive natural biomarkers.
Earli has raised $82m in three rounds from investors including Andreessen Horowitz, Khosla Ventures, Emerson Collective, Stanford, Perceptive Advisors, Casdin Capital, Marc Benioff, Sands Capital, Breyer Capital, Tailwinds (American-Korean) etc.
Its Scientific Advisory Board includes Jim Allison (Nobel Laureate, Immuno Oncology), Bob Langer (MIT, co-founder Moderna), Phil Greenberg (Hutch, co-founder Juno), Pam Sharma (MD Anderson), Charlie Rudin (Sloan Kettering), Alan Ashworth (UCSF Cancer Center).
Who You Are
The Position
Earli Inc. is seeking a high-caliber Senior Director of Business Development to lead our revenue-driving strategic pharma and biotech collaborations, partnerships and outlicensing deals.
Your Primary Responsibilities
As Earli’s Senior Director of Business Development you will be a strategic dealmaker – an individual deeply connected to major pharmaceutical companies, with a proven track record of making deals for collaborations or outlicensing. This role is about developing and driving strategic partnerships and revenue with large pharma companies and successful biotech players in the industry.
You will:
Your Required Experience, Knowledge and Skills
If interested in applying, please attach a CV or have a well-developed LinkedIn profile for us to be able to assess your background.
We look forward to hearing from you!
Website: https://www.earli.com/
Headquarter Location: South San Francisco, California, United States
Employee Count: 11-50
Year Founded: 2018
IPO Status: Private
Last Funding Type: Series A
Industries: Biotechnology ⋅ Health Care ⋅ Medical ⋅ Oncology